Today we interview Anne Sosin of Dartmouth College on public health policy in Vermont and how the state has uniquely tamed the COVID-19 pandemic.

Today we sit down with Dr. Matthew Smith, an associate professor in the Northeastern University Department of Philosophy and Religion, for a far-ranging discussion on COVID-19 from a philosopher's point of view.

Today we are joined by Dr. Aaron Goodman, an Assistant Clinical Professor at the University of California San Diego, who talks with us about hematologic malignancies, transplantation, and our new paper out now in Blood titled "Persistent Challenges with Treating Multiple Myeloma Early".

Today we talk with Dr. Stephen Bradley, a General Practitioner and Clinical Research Fellow at the University of Leeds, on publishing in medical journals -- peer review, editorial practices, anti-intellectualism, and more!

Today we have for you an episode of random thoughts. We talk over the ramifications of the strict COVID-19 policy that prevents people from visiting their dying loved ones in the hospital. We also talk more about Norman Wang and his surrounding controversy given the recent lawsuit the Center for Individual Rights has filed against the University of Pittsburgh on his behalf.

On today's episode we interview Dr. Bill Hall, Associate Professor of Radiation Oncology and Surgery at Medical College of Wisconsin, on our new paper out now in The Lancet Oncology titled "Considering benefit and risk before routinely recommending SpaceOAR".

On today's episode we discuss censorship in medicine in all its forms with legal expert Jonathan Darrow, an Assistant Professor at Harvard Medical School.

On today's episode we talk podcasting and the history of medicine with Dr. Adam Rodman, the creator and host of the wildly popular podcast Bedside Rounds, and a hospitalist at the Beth Israel Deaconess Medical Center.

On today's episode we discuss all the new drugs for acute myeloid leukemia with Dr. Bernie Marini, a Clinical Pharmacist Specialist in Hematology at University of Michigan Medicine.

Today's episode is an interview with Dr. Saurabh Jha, an Associate Professor of Radiology at the Hospital of the University of Pennsylvania, on the importance of debate and dialogue both historically and in today's modern context.

This is the second episode in our experiment in breaking our content up into bite-sized, single-topic episodes. What do you think? Do you prefer a shorter, single-focus episode, or do you prefer our old format?

Now that we are nine months into the COVID-19 pandemic in the United States, we invite Dr. Alasdair Munro, a pediatrics infectious disease expert, back on to the show to discuss recent developments in public health policy concerning the spread of COVID-19, the risk of it, and children. We also talk about the rigorously policed echo chamber of Twitter, specifically #medtwitter, and finding an audience for controversial opinions. This week is also the start of an experiment in breaking our content up into bite-sized, single-topic episodes. What do you think? Do you prefer a shorter, single-focus episode, or do you prefer our old format?

This week we return to our roots of oncology and dissect the recent results from KEYNOTE-177. We also have an in-depth interview with mathematician Dr. Wes Pegden of Carnegie Mellon University on a mathematical approach to the COVID-19 pandemic.

We have a short and sweet episode for you this week -- no monologue, just two deep-dives with two stellar guests. Our first interview is with Dr. Zubin Damania (known as ZDoggMD) and we cover everything from making original music to the artistry of professional oratory to the pain of electronic health records. Our second interview is a return to our popular segment Journal Club with a Fellow: We invite on Dr. Karine Tawagi of the Oschner Clinic in Louisiana to discuss the JAVELIN 100 study.

Our first guests this week are Drs. Adam Cifu and Scott Stern and are on to discuss their new podcast Symptom to Diagnosis -- based on their book of the same name -- about clinical reasoning. Next we bring back political scientist Dr. Vlad Kogan (from episode 3.13) to discuss the need to re-open schools in the context of rising COVID-19 cases and a changing political landscape. Finally we interview Dr. Carycruz Bueno on her critical research into the harms of fully virtual schooling

First up this week we interview constitutional law scholar Leah Litman, an Assistant Professor of Law at the University of Michigan, on Dr. Norman Wang and the intricacies of the laws on affirmative action. Next, we talk with Dr. Patrick DeMartino, a pediatric hematology/oncology fellow at Oregon Health & Science University, on his new paper out now in JAMA Internal Medicine: "Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018". Finally, we sit down with Dr. John Mandrola for an in-depth discussion on the intersection of medicine, politics, and advocacy.

We have a multitude of interviews for you this week. We start by interviewing Dr. Julia Marcus of the Harvard Medical School and Harvard Pilgrim Health Care Institute on messaging around public health interventions during the COVID-19 pandemic. We continue talking about COVID-19 with Anne Sosin and Dr. Elizabeth Carpenter-Song, both of Dartmouth College. They join us on the podcast to discuss how the Northeast region of the United States has uniquely handled COVID-19. Finally, we bring back the Journal Club with a Fellow segment and interview Dr. David Russler-Germain of Washington University School of Medicine in St. Louis on a new paper out now in The Lancet on CAR T-cell therapy in DLBCL: TRANSCEND NHL 001.

We talk this week with Dr. Monica Gandhi, Associate Division Chief of the Division of HIV, Infectious Diseases, and Global Medicine at UCSF/ San Francisco General Hospital, and medical director of the HIV Clinic at SFGH. Speaking from decades of experience treating HIV/AIDS patients, she gives us her take on the public health policies enacted in response to the COVID-19 pandemic. We then conclude this week's episode with a Classical Hematology Chat with Dr. Sven Olson of Oregon Health & Science University.

This week we have two fantastic interviews for you: The first is with Dr. Ben Mazer on the interplay between social media and news; the second is with Dr. Tem Bendapudi on whether Caplacizumab should be the standard of care for thrombotic thrombocytopenic purpura (TTP).

This week we sit down virtually with Dr. Atle Fretheim, Research Director of the Norwegian Institute of Public Health, to talk about how Norway has responded to the COVID-19 crisis - specifically, how they've handled it when it comes to public schools. We also have an interview with Dr. Anthony "Tony" Letai of the Dana Farber Cancer Center on cancer biology.

We start this week's episode off with a monologue covering a few current events, notably the recent editorial on the COVID-19 pandemic in the USA published by the New England Journal of Medicine titled "Dying in a Leadership Vacuum". From there we interview Dr. Margaret McCartney on her recent opinion piece in the BMJ titled "We need better evidence on non-drug interventions for covid-19"; we talk about masks, schools, the need for randomized trials, and more. Finally, we interview Dr. Jason Sheltzer on his recent papers on cancer biology and the implications of his findings on clinical medicine.